Document is current
Any future updates will be listed below
-
Authors
Rowan, Christopher G.
Nichols, Russell M. https://orcid.org/0000-0001-7771-7366
Dhopeshwarkar, Neil
Alyea, Jennifer M.
Zhu, Baojin
Toh, Sengwee
Chan, K. Arnold
Grace, Elsie L.
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 6 December 2024
First Online: 25 December 2024
Declarations
:
: Russell M. Nichols, Jennifer M. Alyea, Baojin Zhu, and Elsie L. Grace are employees and stockholders of Eli Lilly and Company. Neil Dhopeshwarkar and Kinwei Arnold Chan are employees and stockholders of TriNetX, LLC, Cambridge, MA, USA. Christopher G. Rowan served as a consultant for TriNetX, LLC. Sengwee Toh serves as a methods consultant for TriNetX, LLC for this work and unrelated work for Pfizer, Inc, manufacturer of NR.
: No ethics committee was consulted for this study, as it is not considered human subjects research. Exemption from an ethics committee is not required by law or TriNetX policies because the data are fully de-identified per the de-identification standard defined in Sect. 164.514(a) of the HIPAA Privacy Rule and as assessed through formal determination by a qualified expert as defined in Sect. 164.514(b)(1) of the HIPAA Privacy Rule. Additionally, this retrospective study is exempt from informed consent.
